(Press-News.org) Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
The AeroVax study, supported by $8M in funding from the Canadian Institutes of Health Research (CIHR), will test needle-free vaccines developed to provide protection from SARS-CoV-2.
Led by Fiona Smaill and Zhou Xing, members of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster, the multi-centre trial will evaluate the new vaccine in a broad study group, while also confirming safety.
Findings from pre-clinical studies and the soon-to-be-published data from the phase-1 trial indicate that McMaster’s inhaled vaccine is more effective at inducing immune responses than traditional injected vaccines are, because it directly targets the lungs and upper airways — where the virus first enters the body.
“While the current, needle-based COVID-19 vaccines have prevented a tremendous amount of death and hospitalization, they haven’t really changed a lot of people’s experience with getting recurrent infections,” says Smaill, a professor in the Department of Pathology & Molecular Medicine. “So, we’re looking to change that by providing robust protection directly at the site of infection.”
The new vaccine is entirely Canadian, from design and biomanufacturing at McMaster’s Robert E. Fitzhenry Vector Laboratory to pre-clinical and clinical testing conducted by a team of Canadian experts, with Canadian participants, at Canadian research sites.
For the new trial, researchers hope to include 350 participants from across Canada at clinical trial sites in Hamilton, Ottawa, and Halifax. Those eligible for participation must:
Have at least three doses of an mRNA COVID-19 vaccine
Have never received the AstraZeneca COVID-19 vaccine
Have not had a COVID-19 infection or COVID-19 vaccination within three months prior to enrollment
Have no diagnosis of lung disease
Be available to attend trial visits in-person
Be age 18-65
Smaill says that the study is a randomized placebo-controlled trial, noting that two-thirds of the study’s participants will receive the vaccine, while the other third will receive a
placebo. Participants won’t know which group they belong to, but the researchers argue that both groups are equally integral to the study.
“Clinical trials, like this one, are the only way to firmly establish the efficacy and safety of novel health products,” Smaill says. “Randomization allows for objective comparison between those who received the vaccine and those who didn’t, which can tell us a lot about the level of protection the vaccine could provide and its side effects.”
“Every medicine or vaccine that we use and trust today has at one point gone through similar clinical trials processes,” adds Matthew Miller, director of both the IIDR and Global Nexus at McMaster, and part of the trial study team. “This is a highly regulated process with extensive oversight that ensures the safety of participants and will generate critical data to inform the next steps in development.”
Following the study, researchers will move the vaccine into phase-3 clinical trials which will test efficacy in a larger population group and ultimately position the vaccine for market approval.
More information, including how to enrol in the study, is available at aerovax.ca.
Interested in covering the story?
The principal investigator of the study would be happy to speak with you about the AeroVax study and their recruitment for participants. For the phase-2 trial, researchers hope to include 350 participants from across Canada at clinical trial sites in Hamilton, Ottawa, and Halifax. Learn more in the release below.
Fiona Smaill, professor emeritus with McMaster’s Department of Pathology and Molecular Medicine, can be reached at smaill@mcmaster.ca.
---
For any additional information, contact Adam Ward, media relations officer with McMaster’s Faculty of Health Sciences, at warda17@mcmaster.ca.
END
Inhaled COVID vaccine begins recruitment for phase-2 human trials
2025-03-10
ELSE PRESS RELEASES FROM THIS DATE:
What’s in a label? It’s different for boys vs. girls, new study of parents finds
2025-03-10
A decades-old riddle poses the following scenario: A boy is injured in a car crash in which the father dies and is taken to the emergency room, where the doctor says, “I cannot operate on him—he’s my son.” Who, then, is the doctor? Many over the years have been stumped in not recognizing the answer: the mother.
Similarly, research has shown that adults instinctively think of men when asked to think of a person—they describe the most “typical” person they can imagine as male and assume storybook characters without a specified gender are men. A new study by psychology researchers shows that the way parents ...
Genes combined with immune response to Epstein-Barr virus increase MS risk
2025-03-10
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS. The study has been published in the journal PNAS and led by researchers at Karolinska Institutet, Sweden, and Stanford University School of Medicine, USA.
An estimated 90 to 95 percent of adults are carriers of the Epstein-Barr virus (EBV) and have formed antibodies against it. Many become infected as children with few or no symptoms, but in young adults, the virus can cause glandular ...
Proximity and prejudice: Gay discrimination in the gig economy
2025-03-10
University of Queensland research has found discrimination based on sexual orientation is common in the gig economy, but only for tasks requiring close physical proximity.
Dr David Smerdon, Dr Samuel Pearson and Dr Sabina Albrecht ran an experiment on a popular online marketplace involving more than 1,100 job posts across 6 Australian cities.
“To test whether workers discriminate against gay men, we created hundreds of fictitious male ‘requester’ profiles, with some clearly signalling they were gay by referring to their male partner or with a couple profile photo,” Dr Pearson said.
“The requested tasks were either inside the home – such as moving ...
New paper suggests cold temperatures trigger shapeshifting proteins
2025-03-10
Metamorphic proteins can be thought of as the “shapeshifters” of human, animal and bacterial cells. Their ability to drastically switch between two different shapes enables them to adapt to changing environments and carry out diverse functions.
Little is known about how metamorphic proteins transform despite their usefulness in living organisms. To help tackle this mystery, a new paper in the “Perspectives” section of the journal Proceedings of the National Academy of Sciences (PNAS) offers a “bold theory,” said co-author John Orban, a professor in the University of Maryland’s Department ...
Reproductive justice–driven pregnancy interventions can improve mental health
2025-03-10
March 10, 2025 — Perinatal interventions guided by reproductive justice principles can have positive effects on the perinatal mental health of Black birthing patients and, perhaps, the mental health development of their infants, states a systematic review published in a special issue of Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer.
Mental health interventions incorporating reproductive justice principles "utilize a trauma-informed approach to address the psychosocial stress and trauma of racism and their negative effects on pregnant parents and offspring," Cristiane S. Duarte, PhD, MPH, of Columbia University ...
Intranasal herpes infection may produce neurobehavioral symptoms, UIC study finds
2025-03-10
Herpes simplex virus-1 (HSV-1) is commonly known for causing blisters and sores. But in some cases, the virus can migrate to the eye or nervous system, causing severe, chronic symptoms.
Now, a study from University of Illinois Chicago researchers finds that herpes infection through the nose can lead to anxiety, motor impairment and cognitive issues. The research is the first to show that, by exploiting a cellular enzyme, the virus can produce behavioral symptoms. The finding emphasizes the need for prevention and treatment of a virus carried by billions of people worldwide.
The research, published in mBio, is the latest from the College of Medicine group ...
Developing treatment strategies for an understudied bladder disease
2025-03-10
Despite its increasing prevalence, a painful condition called bladder pain syndrome, or interstitial cystitis, remains understudied with limited treatment options. In a new eNeuro paper, Min-Zhi Su and colleagues, from Sun Yat Sen University, used a rat model of bladder pain syndrome to explore if electroacupuncture can alleviate pain and improve bladder function. Electroacupuncture nerve stimulation therapy has shown promise in treating conditions like Huntington’s disease and Amyotrophic Lateral Sclerosis, but researchers have not explored its utility in this context. The researchers discovered that this ...
Investigating how decision-making and behavioral control develop
2025-03-10
Many psychiatric disorders are linked to altered functioning of brain networks that drive reward processing and executive functions like making decisions, taking risks, planning, and memory. But a better understanding of how these networks typically develop to support reward-related executive functions is needed. New in JNeurosci, Samuel Klein and Monica Luciana, from the University of Minnesota, led a longitudinal study to explore how brain networks for reward processing and executive functioning ...
Rutgers researchers revive decades-old pregnancy cohort with modern scientific potential
2025-03-10
The Camden Study, a pregnancy cohort of 4,765 women recruited between 1985 and 2006 from one of America’s poorest cities, has found new life at Rutgers University – where it promises to unlock critical insights into maternal and child health for researchers worldwide.
According to a recent paper in Nutrients, the project was designed to study nutritional status in adolescent pregnancies but expanded into a comprehensive repository of maternal and infant health data that yielded more than a decade of significant ...
Rising CO2 likely to speed decrease in ‘space sustainability’
2025-03-10
Currently more than 8,000 satellites are orbiting at altitudes of between 300 and 1000 km in the Earth’s upper atmosphere – also called the thermosphere. While changes in space weather, such as coronal mass ejections and solar flares, can cause temporary changes in the density of this region, scientists at the University of Birmingham suggest the effects caused by global warming are likely to be much longer term.
This is because of the effects caused by greenhouse gases (GHGs) ...